After hours: March 14 at 7:59:07 PM EDT Loading Chart for MRNA ...

Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell? Investing.com -- Citi has expanded its biopharmaceutical research coverage, initiating coverage on seven ...

The 25,000-subject study is testing a nucleoside-modified mRNA (modRNA), quadrivalent vaccine that is targeted against four strains of the flu virus that the World Health Organization (WHO ...

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes ...

ICIT builds on the promise of circular mRNAs, a new generation of mRNA treatments known for their stability and reduced inflammatory effects compared to traditional linear mRNAs. Unlike linear ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

Vaccines using messenger RNA, or mRNA, technology became widespread during the pandemic. With limited long-term studies available, the Trump administration is revisiting these vaccines. In response to ...

Summary: Scientists have developed a lipid nanoparticle system that enables mRNA to cross the blood-brain barrier, a long-standing challenge in neuroscience. In studies using mice and human brain ...

Dr. Vinod Balachandran says mRNA vaccines could stimulate the immune system to recognize and attack pancreatic cancer cells. An experimental approach to treating pancreatic cancer with the messenger ...